Fluoropharma Medical Stock Number Of Employees
| FPMI Stock | USD 0.0001 0.00 0.00% |
Fluoropharma Medical fundamentals help investors to digest information that contributes to Fluoropharma Medical's financial success or failures. It also enables traders to predict the movement of Fluoropharma Pink Sheet. The fundamental analysis module provides a way to measure Fluoropharma Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fluoropharma Medical pink sheet.
Fluoropharma |
Fluoropharma Medical Company Number Of Employees Analysis
Fluoropharma Medical's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Fluoropharma Medical Number Of Employees | 4 |
Most of Fluoropharma Medical's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fluoropharma Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Fluoropharma Medical is currently employing 4.0 people. This is 99.96% lower than that of the Biotechnology sector and 99.25% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.98% higher than that of the company.
Fluoropharma Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fluoropharma Medical's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fluoropharma Medical could also be used in its relative valuation, which is a method of valuing Fluoropharma Medical by comparing valuation metrics of similar companies.Fluoropharma Medical is currently under evaluation in number of employees category among its peers.
Fluoropharma Fundamentals
| Return On Asset | -2.35 | |||
| Current Valuation | 9.23 M | |||
| Shares Outstanding | 34.26 M | |||
| Shares Owned By Institutions | 0.34 % | |||
| Price To Earning | (0.39) X | |||
| Price To Book | 17.76 X | |||
| EBITDA | (2.16 M) | |||
| Net Income | (2.05 M) | |||
| Cash And Equivalents | 24.72 K | |||
| Total Debt | 5.82 M | |||
| Debt To Equity | 0.07 % | |||
| Book Value Per Share | (0.30) X | |||
| Cash Flow From Operations | (880.12 K) | |||
| Earnings Per Share | (0.08) X | |||
| Target Price | 2.5 | |||
| Beta | -59.92 | |||
| Market Capitalization | 3.43 M | |||
| Total Asset | 334.76 K | |||
| Retained Earnings | (34.16 M) | |||
| Working Capital | (10.23 M) | |||
| Current Asset | 89 K | |||
| Current Liabilities | 10.32 M | |||
| Net Asset | 334.76 K |
About Fluoropharma Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fluoropharma Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fluoropharma Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fluoropharma Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Fluoropharma Pink Sheet
Fluoropharma Medical financial ratios help investors to determine whether Fluoropharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluoropharma with respect to the benefits of owning Fluoropharma Medical security.